ALCAM and cancer: While the CD166 homotypic interactions can play a role in the adhesion of hematopoietic cells to migrasomes, the difference in the absorption of migrasomes observed between KG-1a cancer cells and CD34+ HSPCs might be a result, among others, of additional proteins that interact with CD166 [52].